Entrada Therapeutics (TRDA) announced the appointment of Dr. Bernhardt "Bernie" Zeiher to its Board of Directors, effective immediately. Dr. Zeiher served most recently as the Chief Medical Officer at Astellas Pharma (ALPMY).
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TRDA:
- Entrada Therapeutics Appoints Dr. Bernhardt Zeiher to its Board of Directors
- Entrada Therapeutics initiated with a Buy at H.C. Wainwright
- Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference
- Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
- Entrada Therapeutics expects cash to fund requirements into 2H25